R
Ross Garberich
Researcher at Abbott Northwestern Hospital
Publications - 172
Citations - 5364
Ross Garberich is an academic researcher from Abbott Northwestern Hospital. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 30, co-authored 150 publications receiving 3992 citations. Previous affiliations of Ross Garberich include Tufts Medical Center & Medtronic plc.
Papers
More filters
Journal ArticleDOI
Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic.
Santiago Garcia,Mazen Albaghdadi,Perwaiz Meraj,Christian W. Schmidt,Ross Garberich,Farouc A. Jaffer,Simon R. Dixon,Jeffrey J. Rade,Mark Tannenbaum,Jenny Chambers,Paul P Huang,Timothy D. Henry +11 more
TL;DR: The COVID-19 pandemic has significantly affected the U.S. health care system and the Centers for Disease Control and Prevention recommended deferral of elective cardiac procedures.
Journal ArticleDOI
Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
Barry J. Maron,Ethan J. Rowin,Susan A. Casey,Mark S. Link,John R. Lesser,Raymond H. Chan,Ross Garberich,James E. Udelson,Martin S. Maron +8 more
TL;DR: In a large longitudinally assessed adult HCM cohort, it is demonstrated that contemporary management strategies and treatment interventions, including ICDs for SD prevention, have significantly altered the clinical course, now resulting in a low disease-related mortality rate of 0.5%/year and an opportunity for extended longevity.
Journal ArticleDOI
Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy
Barry J. Maron,Paolo Spirito,Michael J. Ackerman,Susan A. Casey,Christopher Semsarian,N.A. Mark Estes,Kevin Shannon,Euan A. Ashley,Sharlene M. Day,Giuseppe Pacileo,Francesco Formisano,Emmanuela Devoto,A. Anastasakis,J. Martijn Bos,Anna Woo,Camillo Autore,Robert H. Pass,Giuseppe Boriani,Ross Garberich,Adrian K. Almquist,Mark W. Russell,Luca Boni,Stuart Berger,Martin S. Maron,Mark S. Link +24 more
TL;DR: In a high-risk pediatric HCM cohort, ICD interventions terminating life-threatening ventricular tachyarrhythmias were frequent and extreme left ventricular hypertrophy was the most common risk factor present in patients experiencing primary prevention interventions.
Journal ArticleDOI
Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management
Ethan J. Rowin,Barry J. Maron,Tammy S. Haas,Ross Garberich,Weijia Wang,Mark S. Link,Martin S. Maron +6 more
TL;DR: HCM patients with LV apical aneurysms are at high risk for arrhythmic sudden death and thromboembolic events and identification of this phenotype expands risk stratification and can lead to effective treatment interventions for potentially life-threatening complications.
Journal ArticleDOI
Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry
TL;DR: Within this large forensic registry of competitive athletes, cardiovascular sudden deaths due to genetic and/or congenital heart diseases were uncommon in females and more common in African Americans/other minorities than in whites.